Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 4/20 | 0.50 |
| ▸ | CCR8 | P51685 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | CCR5 | P51681 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14884167 | 0.90 | CCR1 (0.42) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884183 | 0.90 | MAPT (0.42) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884190 | 0.88 | CCR1 (0.41) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL27977304 | 0.85 | CCR1 (0.41) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884189 | 0.83 | CCR1 (0.37) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884176 | 0.83 | CCR1 (0.37) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884171 | 0.82 | ALDH1A1 (0.36) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL14884192 | 0.80 | CCR1 (0.38) | CCR1CCR8LMNAKDM4EMAPT | |
| SCHEMBL360716 | 0.79 | LPL (0.42) | KDM4EMAPTTDP1TSHRL3MBTL1 | |
| SCHEMBL14884174 | 0.79 | ALDH1A1 (0.38) | CCR1CCR8LMNAKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110437-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025020676-A1 | ORGANIC ELECTROLUMINESCENT DEVICE HAVING HIGH PERFORMANCE AND COMPOUND THEREOF | 京东方科技集团股份有限公司 | 2025-01-30 | — | — | WO | disclosed |
| US-20240092776-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-03-21 | — | — | US | disclosed |
| CN-110099902-B | Novel compound and organic light-emitting element comprising same | 株式会社LG化学 | 2022-07-01 | — | — | CN | disclosed |
| US-20210130355-A1 | COMPOUND, ELECTRON TRANSPORT MATERIAL, DISPLAY PANEL AND DISPLAY APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2021-05-06 | — | — | US | disclosed |
| US-20200235315-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-23 | — | — | US | disclosed |
| US-20200095224-A1 | NITROGEN HETEROCYCLIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2020-03-26 | — | — | US | disclosed |
| EP-2778160-B1 | CYCLIC AZINE COMPOUND HAVING NITROGEN-CONTAINING FUSED AROMATIC GROUP, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME AS CONSTITUENT COMPONENT | TOSOH CORP (JP) | 2018-01-10 | — | — | EP | disclosed |
| WO-2017179809-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2017-10-19 | — | — | WO | disclosed |
| US-9252368-B2 | Cyclic azine compound having nitrogen-containing condensed aromatic group, method for producing same, and organic electroluminescent device comprising same as constituent component | TOSOH CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-9252368-B2 | Cyclic azine compound having nitrogen-containing condensed aromatic group, method for producing same, and organic electroluminescent device comprising same as constituent component | TOSOH CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-9252368-B2 | Cyclic azine compound having nitrogen-containing condensed aromatic group, method for producing same, and organic electroluminescent device comprising same as constituent component | TOSOH CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20140330013-A1 | CYCLIC AZINE COMPOUND HAVING NITROGEN-CONTAINING FUSED AROMATIC GROUP, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140330013-A1 | CYCLIC AZINE COMPOUND HAVING NITROGEN-CONTAINING FUSED AROMATIC GROUP, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140330013-A1 | CYCLIC AZINE COMPOUND HAVING NITROGEN-CONTAINING FUSED AROMATIC GROUP, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| EP-2778160-A1 | CYCLIC AZINE COMPOUND HAVING NITROGEN-CONTAINING FUSED AROMATIC GROUP, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME AS CONSTITUENT COMPONENT | Tosoh Corporation (JP) | 2014-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092776-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | ORC3, CRY1, CRY2 | CCR1 4156/4885CCR8 2785/4885LMNA 3638/4885 |
| US-20200235315-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | TRPA1, PIEZO1, SLCO4C1 | CCR1 1980/4885CCR8 1419/4885LMNA 1366/4885 |
| US-20200095224-A1 | NITROGEN HETEROCYCLIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | C5, CCND2, OCIAD2 | CCR1 283/4885CCR8 906/4885LMNA 1160/4885 |
| US-20210130355-A1 | COMPOUND, ELECTRON TRANSPORT MATERIAL, DISPLAY PANEL AND DISPLAY APPARATUS | KCNQ4, TRPC4, KCNQ1 | CCR1 991/4885CCR8 1925/4885LMNA 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.